Search Results - cd programme

  1. GEOCHEMICAL CHARACTERISATION OF SOILS AND SEDIMENTS FROM ONITSHA METROPOLIS, SOUTHEASTERN NIGERIA

    Published 2017-04
    Full Text Available
    Access Repository
    Thesis
  2. The impact of the HPTN 071 (PopART) intervention on mortality and AIDS related morbidity amongst HIV positive adults in South Africa by Bock, Peter

    Published 2018
    Get full text
    Thesis
  3. A survey of students’ perception of the role and image of school librarians in Ibadan south west local government area of Oyo state

    Published 2012
    Full Text Available
    Access Repository
    Article
  4. Survival of adults with HIV-1 infection or Type 2 diabetes in the South African private sector by Sarkin, Lee

    Published 2020
    “…Baseline CD4 count was only prognostic for relative risk within the first three years of ART after adjusting for the immunological and virological response to ART. …”
    Get full text
    Thesis
  5. The natural history of Efavirenz Drug Induced liver injury by Maughan, Deborah

    Published 2021
    “…Background Efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor (NNRTI), has been a component of first line antiretroviral treatment in the South African HIV/AIDS programme since 2004. Similarly, it is extensively used in ART programmes in other low and middle incomes countries. …”
    Get full text
    Thesis
  6. Modelling early iInitiation of HAART to forestall AIDS-related lymphoma in South Africa: a cost-effectiveness analysis. by Kyomugisha, Irene

    Published 2017
    Get full text
    Thesis
  7. Clinical mentorship of nurse-initiated Antiretroviral Therapy (ART) in Khayelitsha, South Africa: a quality of care assessment by Green, Ann

    Published 2014
    Get full text
    Thesis
  8. Human immunodeficiency virus (HIV) and Human papillomavirus (HPV) infection and cell cycle regulators in preinvasive lesions and invasive carcinomas of the anus by De Jager, Louis Johann

    Published 2017
    “…Differentiation, subtype of squamous cell carcinoma and HIV status did not influence the density of CD1a/Langerin-positive Langerhans cells. No significant difference in the density of CD1a/Langerin-positive cells was demonstrated amongst normal, dysplastic and squamous cell carcinoma tissue, regardless of HIV status. …”
    Get full text
    Thesis
  9. Evaluation of a quality improvement cycle intervention in the provision of PMTCT at a regional hospital by Van Niekerk, Elizabeth C.

    Published 2013
    Get full text
    Thesis
  10. Modeling the impact of early HIV treatment on the HIV epidemic in South Africa by Bekele, Bewketu Teshale

    Published 2016
    Get full text
    Thesis
  11. Characterization of and risk factors for HIV-1 resistance mutations following first line antiretroviral failure in the southern African private sector by Lutaaya, Leonard Edgar

    Published 2017
    “…Variables included in analyses were age, gender, province, WHO stage at time of resistance testing (HIVDR), duration of ART at HIVDR, prior monotherapy or dual therapy, viral load and CD4 count prior to starting ART, viral load and CD4 count at HIVDR, duration that the viral load was >400 copies/ml prior to HIVDR and HIV subtype. …”
    Get full text
    Thesis
  12. Morbidity from antiretroviral metabolic effects in Africa: The Mama Study by Karamchand, Sumanth

    Published 2018
    “…The following variables were adjusted for in the regression model: age, sex, baseline BMI, baseline CD4, baseline viral load, exposure to diabetogenic drugs, and nucleoside reverse transcriptase inhibitor (NRTI) exposure. …”
    Get full text
    Thesis
  13. Cellular immune ontogeny and birth transcriptome in HIV-exposed uninfected infants by Kiravu, Agano

    Published 2021
    “…In cross-sectional unadjusted analyses however, trends towards increased median frequencies of markers of activation in the HEU group compared to HU controls were observed for specific ages: at birth (%CD8+HLA-DR+: 0.12 vs. 0.01, p=0.05), at week 7 (%CD8+CD25+: 0.13 vs. 0.04, p=0.01 and %CD8+HLA-DR+: 0.84 vs. 0.07, p=0.01) and at week 36 (%CD8+CD25+: 0.52 vs. 0.03, p< 0.001 and %CD8+HLA-DR+: 0.81 vs. 0.17, p=0.003). …”
    Get full text
    Thesis
  14. Outcomes and cost-effectiveness of different models of delivery of antiretroviral therapy by Leisegang, Rory

    Published 2018
    “…In the first analysis (Chapter 4), we present a cohort profile for Aid for AIDS, where we describe the history of the programme and contrast it with the public sector programme in South Africa. …”
    Get full text
    Thesis